lucanthone has been researched along with Adenocarcinoma, Basal Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gatz, M; Padawer, J; Rettura, G; Seifter, E; Thysen, B | 1 |
| Prescott, B | 1 |
2 other study(ies) available for lucanthone and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Combined treatment with radioestradiol-lucanthone in mouse C3HBA mammary adenocarcinoma and with estradiol-lucanthone in an estrogen bioassay.
Topics: Adenocarcinoma; Animals; Biological Assay; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol; Female; Lucanthone; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Organ Size; Prognosis; Tritium | 1981 |
Some new salts of lucanthone as potential anticancer agents.
Topics: Adenocarcinoma; Animals; Leukemia L1210; Lucanthone; Methods; Mice; Sarcoma 180; Sulfonic Acids | 1968 |